|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Net sales | ||||
| Costs of sales | ||||
| Gross profit | ||||
| Selling, general and administrative expense | ||||
| Transaction, restructuring and integration expense | ||||
| Impairment charges | ||||
| Loss (gain) on disposal of property, plant and equipment | ||||
| Total operating expenses | ||||
| Loss from operations | ||||
| Interest expense | ||||
| Change in fair value of warrant liabilities | ||||
| Other, net | ||||
| Loss before income taxes and equity in earnings from unconsolidated entities | ||||
| Income tax expense (benefit) | ||||
| Equity in (earnings) loss from unconsolidated entities | ||||
| Net loss | ||||
| Net loss attributable to non-controlling interest | ||||
| Net loss attributable to shareholders | ||||
| Amortization (accretion) of Series A Convertible Preferred Shares | ||||
| Net loss attributable to common shareholders | ||||
| (Loss) earnings per common share: | ||||
| Basic (in dollars per share) | ||||
| Diluted (in dollars per share) | ||||
| Weighted-average number of shares outstanding: | ||||
| Basic (in shares) | ||||
| Diluted (in shares) | ||||
Loading...